Literature DB >> 25712989

Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.

Claire S Whyte1, Frauke Swieringa2, Tom G Mastenbroek2, Ausra S Lionikiene1, Marcus D Lancé2, Paola E J van der Meijden2, Johan W M Heemskerk2, Nicola J Mutch1.   

Abstract

The interaction of plasminogen with platelets and their localization during thrombus formation and fibrinolysis under flow are not defined. Using a novel model of whole blood thrombi, formed under flow, we examine dose-dependent fibrinolysis using fluorescence microscopy. Fibrinolysis was dependent upon flow and the balance between fibrin formation and plasminogen activation, with tissue plasminogen activator-mediated lysis being more efficient than urokinase plasminogen activator-mediated lysis. Fluorescently labeled plasminogen radiates from platelet aggregates at the base of thrombi, primarily in association with fibrin. Hirudin attenuates, but does not abolish plasminogen binding, denoting the importance of fibrin. Flow cytometry revealed that stimulation of platelets with thrombin/convulxin significantly increased the plasminogen signal associated with phosphatidylserine (PS)-exposing platelets. Binding was attenuated by tirofiban and Gly-Pro-Arg-Pro amide, confirming a role for fibrin in amplifying plasminogen binding to PS-exposing platelets. Confocal microscopy revealed direct binding of plasminogen and fibrinogen to different platelet subpopulations. Binding of plasminogen and fibrinogen co-localized with PAC-1 in the center of spread platelets. In contrast, PS-exposing platelets were PAC-1 negative, and bound plasminogen and fibrinogen in a protruding "cap." These data show that different subpopulations of platelets harbor plasminogen by diverse mechanisms and provide an essential scaffold for the accumulation of fibrinolytic proteins that mediate fibrinolysis under flow.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25712989      PMCID: PMC4400293          DOI: 10.1182/blood-2014-09-599480

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  67 in total

1.  On the kinetics of the reaction between human antiplasmin and plasmin.

Authors:  B Wiman; D Collen
Journal:  Eur J Biochem       Date:  1978-03-15

2.  Measurement of whole blood thrombus formation using parallel-plate flow chambers - a practical guide.

Authors:  Roger Van Kruchten; Judith M E M Cosemans; Johan W M Heemskerk
Journal:  Platelets       Date:  2012       Impact factor: 3.862

3.  Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial.

Authors:  M D Lancé; M Ninivaggi; S E M Schols; M A H Feijge; S K Oehrl; G J A J M Kuiper; M Nikiforou; M A E Marcus; K Hamulyak; E C M van Pampus; H ten Cate; J W M Heemskerk
Journal:  Vox Sang       Date:  2011-12-28       Impact factor: 2.144

4.  The presence and release of alpha 2-antiplasmin from human platelets.

Authors:  E F Plow; D Collen
Journal:  Blood       Date:  1981-12       Impact factor: 22.113

5.  Factor XIII supports platelet activation and enhances thrombus formation by matrix proteins under flow conditions.

Authors:  S G Magwenzi; R A Ajjan; K F Standeven; L A Parapia; K M Naseem
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

6.  Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse.

Authors:  Shahrokh Falati; Peter Gross; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

7.  Platelet factor XIII and calpain negatively regulate integrin alphaIIbbeta3 adhesive function and thrombus growth.

Authors:  Suhasini Kulkarni; Shaun P Jackson
Journal:  J Biol Chem       Date:  2004-05-06       Impact factor: 5.157

8.  Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI.

Authors:  N J Mutch; N R Moore; E Wang; N A Booth
Journal:  J Thromb Haemost       Date:  2003-09       Impact factor: 5.824

9.  Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions.

Authors:  Judith A Coppinger; Gerard Cagney; Sinead Toomey; Thomas Kislinger; Orina Belton; James P McRedmond; Dolores J Cahill; Andrew Emili; Desmond J Fitzgerald; Patricia B Maguire
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

10.  Hindered dissolution of fibrin formed under mechanical stress.

Authors:  I Varjú; P Sótonyi; R Machovich; L Szabó; K Tenekedjiev; M M C G Silva; C Longstaff; K Kolev
Journal:  J Thromb Haemost       Date:  2011-05       Impact factor: 5.824

View more
  27 in total

1.  Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system.

Authors:  Yuko Suzuki; Hideto Sano; Liina Mochizuki; Naoki Honkura; Tetsumei Urano
Journal:  Blood Adv       Date:  2020-11-10

Review 2.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

3.  Identification of key lipids critical for platelet activation by comprehensive analysis of the platelet lipidome.

Authors:  Bing Peng; Sascha Geue; Cristina Coman; Patrick Münzer; Dominik Kopczynski; Canan Has; Nils Hoffmann; Mailin-Christin Manke; Florian Lang; Albert Sickmann; Meinrad Gawaz; Oliver Borst; Robert Ahrends
Journal:  Blood       Date:  2018-05-21       Impact factor: 22.113

4.  Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity.

Authors:  Joanne L Mitchell; Ausra S Lionikiene; Georgi Georgiev; Anja Klemmer; Chelsea Brain; Paul Y Kim; Nicola J Mutch
Journal:  Blood       Date:  2016-09-30       Impact factor: 22.113

5.  Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.

Authors:  H M H Spronk; T Padro; J E Siland; J H Prochaska; J Winters; A C van der Wal; J J Posthuma; G Lowe; E d'Alessandro; P Wenzel; D M Coenen; P H Reitsma; W Ruf; R H van Gorp; R R Koenen; T Vajen; N A Alshaikh; A S Wolberg; F L Macrae; N Asquith; J Heemskerk; A Heinzmann; M Moorlag; N Mackman; P van der Meijden; J C M Meijers; M Heestermans; T Renné; S Dólleman; W Chayouâ; R A S Ariëns; C C Baaten; M Nagy; A Kuliopulos; J J Posma; P Harrison; M J Vries; H J G M Crijns; E A M P Dudink; H R Buller; Y M C Henskens; A Själander; S Zwaveling; O Erküner; J W Eikelboom; A Gulpen; F E C M Peeters; J Douxfils; R H Olie; T Baglin; A Leader; U Schotten; B Scaf; H M M van Beusekom; L O Mosnier; L van der Vorm; P Declerck; M Visser; D W J Dippel; V J Strijbis; K Pertiwi; A J Ten Cate-Hoek; H Ten Cate
Journal:  Thromb Haemost       Date:  2018-01-29       Impact factor: 5.249

Review 6.  Alterations in platelet behavior after major trauma: adaptive or maladaptive?

Authors:  Paul Vulliamy; Lucy Z Kornblith; Matthew E Kutcher; Mitchell J Cohen; Karim Brohi; Matthew D Neal
Journal:  Platelets       Date:  2020-01-27       Impact factor: 3.862

7.  Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis.

Authors:  Sarah N Lauder; Keith Allen-Redpath; David A Slatter; Maceler Aldrovandi; Anne O'Connor; Daniel Farewell; Charles L Percy; Jessica E Molhoek; Sirpa Rannikko; Victoria J Tyrrell; Salvatore Ferla; Ginger L Milne; Alastair W Poole; Christopher P Thomas; Samya Obaji; Philip R Taylor; Simon A Jones; Phillip G de Groot; Rolf T Urbanus; Sohvi Hörkkö; Stefan Uderhardt; Jochen Ackermann; P Vince Jenkins; Andrea Brancale; Gerhard Krönke; Peter W Collins; Valerie B O'Donnell
Journal:  Sci Signal       Date:  2017-11-28       Impact factor: 8.192

Review 8.  Phospholipid signaling in innate immune cells.

Authors:  Valerie B O'Donnell; Jamie Rossjohn; Michael Jo Wakelam
Journal:  J Clin Invest       Date:  2018-04-23       Impact factor: 14.808

9.  Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets.

Authors:  Ran Ni; Miguel A D Neves; Chengliang Wu; Samantha E Cerroni; Matthew J Flick; Heyu Ni; Jeffrey I Weitz; Peter L Gross; Paul Y Kim
Journal:  J Thromb Haemost       Date:  2020-09       Impact factor: 5.824

10.  Exposure of plasminogen and a novel plasminogen receptor, Plg-RKT, on activated human and murine platelets.

Authors:  Claire S Whyte; Gael B Morrow; Nagyung Baik; Nuala A Booth; Mohammed M Jalal; Robert J Parmer; Lindsey A Miles; Nicola J Mutch
Journal:  Blood       Date:  2021-01-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.